New research has found a wide variation in the extensive use of CT scans in elderly stroke patients across hospitals in the U.S., according to findings published online Oct. 29 in Radiology.

The FDA has given clearance to the Prime edition of the ACUSON SC2000 premium cardiovascular imaging system from Siemens Healthcare.

The FDA has approved the CapSureFix Novus MRI SureScan 5076 Lead from Minneapolis-based Medtronic. The lead is approved for MRI scans on any region of the body when paired with a dual-chamber MR-conditional pacemaker.

Up to two-thirds of neurologists inaccurately interpreted advanced imaging tests used to detect strokes in initial findings from a survey presented at the Canadian Stroke Congress in Vancouver.

The FDA has approved Lumason, the microbubble contrast agent marketed by Bracco Diagnostics.

St. Johns Hospital and Medical Center in Detroit recently became the first U.S. health care facility to install the Artis one angiography system from Siemens Healthcare.

Stroke patients who were selected by perfusion CT for intravenous thrombolytic treatment more than three hours after symptoms occurred had favorable outcomes, according to a literature review published online on Sept. 19 in Radiology. 

Lowering the amount of iodinated contrast medium (ICM) administered intravenously to high-risk patients before a CT scan to less than 90 ml reduces the risk of contrast-induced acute kidney injury (CI-AKI), according to a study published in the October edition of Clinical Radiology.